Seguro Acquires Worldwide Rights to Johns Hopkins Abdominal Surgery Device

COLUMBIA, Md., Oct. 19 /PRNewswire/ -- Seguro Surgical, Inc., a medical device
development company specializing in the commercialization of surgical
instrumentation, today announced that it has acquired, from The Johns Hopkins
University, the global marketing rights to a novel device for use in abdominal
surgery.

Over two million abdominal surgeries (laparotomies) are performed annually in
the United States. Current practice utilizes cotton towels or sponges to
reposition the bowel and allow access to the surgical area. This procedure is
time consuming, presents potential safety risks to patients and can lead to
post-operative complications. Seguro's "Lap-Pak" device is a flexible,
one-piece, device contoured to enable the rapid and secure re-positioning of
the bowels to expose the surgical site.

The device was developed by surgeons and biomedical engineering students from
the BME undergraduate design course at Johns Hopkins under the leadership of
Robert E. Bristow, M.D., M.B.A., Professor, Director, Kelly Gynecological
Oncology Service and Director, Johns Hopkins Ovarian Cancer Center of
Excellence.

Dr. Steve Kubisen, President and Chief Executive Officer of Seguro, stated,
"We believe that this elegantly simple device will improve the overall
efficiency of laparotomies and generate substantial reductions in overall
healthcare costs. We are very excited to be working with Johns Hopkins and
hope that this will be the first of many collaborative ventures that we
undertake together."

Seguro is a portfolio company of FirstStage Bioventures LLC, an investment
company which creates value through the licensing, development and ultimate
sale of early stage medical technologies. For more information see the
company's website at www.segurosurgical.com.

SOURCE Seguro Surgical, Inc.

Steven J. Kubisen, President and CEO of Seguro Surgical, +1-410-772-2295,
skubisen@segurosurgical.com